NetworkNewsBreaks – ChineseInvestors.com Inc. (C
Post# of 346
(Total Views: 138)
Posted On: 10/24/2019 4:49:59 PM
NetworkNewsBreaks – ChineseInvestors.com Inc. (CIIX) Establishing Strong Position in Chinese CBD-Based Nutrition, Health-Product Market
ChineseInvestors.com (OTCQB: CIIX), a financial news and investment portal for the global Chinese-speaking community, is establishing itself as a major player in the emerging CBD market for CBD-based nutrition and health products in China. An article discussing the company reads, “Through wholly owned enterprise CBD Biotech Inc., CIIX is implementing its CBD initiatives. At present, CIIX is at the vanguard of what may become be the globe’s largest CBD market: China (www.CIIXInfo.com). The company recognizes the untapped CBD market for Chinese-speaking individuals, specifically in the health-care sector, which is expected to grow by as much as 10% per year. Due to a higher spending power from consumers, China’s demand for medicinal products such as those made from hemp-based CBD has risen. Analysts foresee China’s CBD market reaching over $20 billion by 2022, and CIIX is uniquely positioned to meet this consumer demand. CIIX is hoping for a Nasdaq IPO of CBD Biotech late in FY2019 or early in 2020.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
ChineseInvestors.com (OTCQB: CIIX), a financial news and investment portal for the global Chinese-speaking community, is establishing itself as a major player in the emerging CBD market for CBD-based nutrition and health products in China. An article discussing the company reads, “Through wholly owned enterprise CBD Biotech Inc., CIIX is implementing its CBD initiatives. At present, CIIX is at the vanguard of what may become be the globe’s largest CBD market: China (www.CIIXInfo.com). The company recognizes the untapped CBD market for Chinese-speaking individuals, specifically in the health-care sector, which is expected to grow by as much as 10% per year. Due to a higher spending power from consumers, China’s demand for medicinal products such as those made from hemp-based CBD has risen. Analysts foresee China’s CBD market reaching over $20 billion by 2022, and CIIX is uniquely positioned to meet this consumer demand. CIIX is hoping for a Nasdaq IPO of CBD Biotech late in FY2019 or early in 2020.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)